Abstract
Purpose
Although adrenal computed tomography (CT) percentage washout is a potentially powerful imaging technique for differentiating adrenal adenomas from non-adenomas, its application to non-adenomas can be problematic. Recently, modified criteria for diagnosing pheochromocytomas using adrenal CT were developed based on data from 199 patients with surgically proven pheochromocytomas and adenomas. However, these criteria have not been thoroughly validated. The purpose of this study was to validate the performance of the modified criteria for diagnosing non-adenomas including pheochromocytomas.
Methods
The conventional and modified criteria were applied to 266 patients from two cohorts who had surgically proven lipid-poor adenomas (155/266, 58.3%) and non-adenomas (111/266, 41.7%) and underwent adrenal CT. Two radiologists calculated the attenuation on each dynamic phase and percentage washout of adrenal masses. The final assessments based on the conventional and modified criteria were categorized into adenomas or non-adenomas. The diagnostic performance of each criterion for diagnosing non-adenomas was evaluated using the area under the receiver operating characteristic curve (AUC). False negatives and positives were also compared.
Results
The AUC for the diagnosis of non-adenomas was 0.806 for conventional criteria and 0.858 for modified criteria (p = 0.047). The false-negative rate of conventional criteria for the diagnosis of non-adenomas was 29.7%. Use of modified criteria could have reduced the false-negative rate by to 7.2%. The false-positive rate increased from 9% to 21.3% when using the modified criteria.
Conclusion
The utilization of modified criteria has the potential to identify additional non-adenomas that would otherwise be misdiagnosed as adenomas using conventional criteria alone.
Graphical abstract
Similar content being viewed by others
References
Ctvrtlik F, Koranda P, Tichy T (2014) Adrenal disease: a clinical update and overview of imaging. A review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 158:23-34. https://doi.org/https://doi.org/10.5507/bp.2014.010
Johnson PT, Horton KM, Fishman EK (2009) Adrenal mass imaging with multidetector CT: pathologic conditions, pearls, and pitfalls. Radiographics 29:1333-1351. https://doi.org/https://doi.org/10.1148/rg.295095027
Woo S, Suh CH, Kim SY, Cho JY, Kim SH (2018) Pheochromocytoma as a frequent false-positive in adrenal washout CT: A systematic review and meta-analysis. Eur Radiol 28:1027-1036. https://doi.org/https://doi.org/10.1007/s00330-017-5076-5
Patel J, Davenport MS, Cohan RH, Caoili EM (2013) Can established CT attenuation and washout criteria for adrenal adenoma accurately exclude pheochromocytoma? AJR Am J Roentgenol 201:122-127. https://doi.org/https://doi.org/10.2214/AJR.12.9620
Park BK, Kim B, Ko K, Jeong SY, Kwon GY (2006) Adrenal masses falsely diagnosed as adenomas on unenhanced and delayed contrast-enhanced computed tomography: pathological correlation. Eur Radiol 16:642-647. https://doi.org/https://doi.org/10.1007/s00330-005-0017-0
Park BK, Kim CK, Kwon GY, Kim JH (2007) Re-evaluation of pheochromocytomas on delayed contrast-enhanced CT: washout enhancement and other imaging features. Eur Radiol 17:2804-2809. https://doi.org/https://doi.org/10.1007/s00330-007-0695-x
Kang S, Oh YL, Park SY (2021) Distinguishing pheochromocytoma from adrenal adenoma by using modified computed tomography criteria. Abdom Radiol (NY) 46:1082-1090. https://doi.org/https://doi.org/10.1007/s00261-020-02764-4
Lanoix J, Djelouah M, Chocardelle L, Deguelte S, Delemer B, Dohan A, Soyer P, Barat M, Hoeffel C (2022) Differentiation between heterogeneous adrenal adenoma and non-adenoma adrenal lesion with CT and MRI. Abdom Radiol (NY) 47:1098-1111. https://doi.org/https://doi.org/10.1007/s00261-022-03409-4
Boland GW, Lee MJ, Gazelle GS, Halpern EF, McNicholas MM, Mueller PR (1998) Characterization of adrenal masses using unenhanced CT: an analysis of the CT literature. AJR Am J Roentgenol 171:201-204. https://doi.org/https://doi.org/10.2214/ajr.171.1.9648789
Motta-Ramirez GA, Remer EM, Herts BR, Gill IS, Hamrahian AH (2005) Comparison of CT findings in symptomatic and incidentally discovered pheochromocytomas. AJR Am J Roentgenol 185:684-688. https://doi.org/https://doi.org/10.2214/ajr.185.3.01850684
Fassnacht M, Tsagarakis S, Terzolo M, Tabarin A, Sahdev A, Newell-Price J, Pelsma I, Marina L, Lorenz K, Bancos I (2023) European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. European Journal of Endocrinology 189:G1-G42
Vilar L, da Conceição Freitas M, Canadas V, Albuquerque JL, Botelho CA, Egito CS, Arruda MJ, Moura L, Coelho CE, Casulari LA (2008) Adrenal incidentalomas: diagnostic evaluation and long-term follow-up. Endocrine practice 14:269-278
Hong AR, Kim JH, Park KS, Kim KY, Lee JH, Kong SH, Lee SY, Shin CS, Kim SW, Kim SY (2017) Optimal follow-up strategies for adrenal incidentalomas: reappraisal of the 2016 ESE-ENSAT guidelines in real clinical practice. European journal of endocrinology 177:475-483
Marty M, Gaye D, Perez P, Auder C, Nunes M, Ferriere A, Haissaguerre M, Tabarin A (2018) Diagnostic accuracy of computed tomography to identify adenomas among adrenal incidentalomas in an endocrinological population. European Journal of Endocrinology 178:439-446
Bancos I, Taylor AE, Chortis V, Sitch AJ, Lang K, Prete A, Gilligan LC, Biehl M, Deeks JJ, Arlt W (2020) Urine metabolomic phenotyping for detection of adrenocortical carcinoma: still a long way to go–Authors' reply. The Lancet Diabetes & Endocrinology 8:877-878
Duh Q-Y (2020) Understanding the epidemiology of adrenal tumours. The Lancet Diabetes & Endocrinology 8:871-873
Schloetelburg W, Ebert I, Petritsch B, Weng AM, Dischinger U, Kircher S, Buck AK, Bley TA, Deutschbein T, Fassnacht M (2022) Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant adrenal masses. European Journal of Endocrinology 186:183-193
Park SY, Park BK, Park JJ, Kim CK (2016) Differentiation of adrenal hyperplasia from adenoma by use of CT densitometry and percentage washout. American Journal of Roentgenology 206:106-112
Doppman J, Gill Jr J, Miller D, Chang R, Gupta R, Friedman T, Choyke P, Feuerstein I, Dwyer A, Jicha D (1992) Distinction between hyperaldosteronism due to bilateral hyperplasia and unilateral aldosteronoma: reliability of CT. Radiology 184:677-682
Lattin Jr GE, Sturgill ED, Tujo CA, Marko J, Sanchez-Maldonado KW, Craig WD, Lack EE (2014) From the radiologic pathology archives: Adrenal tumors and tumor-like conditions in the adult: radiologic-pathologic correlation. Radiographics 34:805-829
Schieda N, Siegelman ES (2017) Update on CT and MRI of Adrenal Nodules. AJR Am J Roentgenol 208:1206-1217. https://doi.org/https://doi.org/10.2214/AJR.16.17758
Korobkin M, Brodeur FJ, Yutzy GG, Francis IR, Quint LE, Dunnick NR, Kazerooni EA (1996) Differentiation of adrenal adenomas from nonadenomas using CT attenuation values. AJR. American journal of roentgenology 166:531-536
Lee MJ, Hahn PF, Papanicolaou N, Egglin TK, Saini S, Mueller PR, Simeone JF (1991) Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis. Radiology 179:415-418
Kim MJ, Kang KA, Kim CK, Park SY (2023) Inter-method agreement between wash-in and wash-out computed tomography for characterizing hyperattenuating adrenal lesions as adenomas or non-adenomas. European Radiology 33:2218-2226
Kang S, Oh YL, Park SY (2021) Distinguishing pheochromocytoma from adrenal adenoma by using modified computed tomography criteria. Abdominal Radiology 46:1082-1090
Park SY, Park BK, Park JJ, Kim CK (2015) CT sensitivities for large (≥ 3 cm) adrenal adenoma and cortical carcinoma. Abdominal imaging 40:310-317
Sun MR, Ngo L, Genega EM, Atkins MB, Finn ME, Rofsky NM, Pedrosa I (2009) Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes—correlation with pathologic findings. Radiology 250:793-802
Jakobsson U, Westergren A (2005) Statistical methods for assessing agreement for ordinal data. Scand J Caring Sci 19:427-431. https://doi.org/https://doi.org/10.1111/j.1471-6712.2005.00368.x
Lenders JW, Pacak K, Walther MM, Linehan WM, Mannelli M, Friberg P, Keiser HR, Goldstein DS, Eisenhofer G (2002) Biochemical diagnosis of pheochromocytoma: which test is best? Jama 287:1427-1434
Schieda N, Alrashed A, Flood TA, Samji K, Shabana W, McInnes MD (2016) Comparison of Quantitative MRI and CT Washout Analysis for Differentiation of Adrenal Pheochromocytoma From Adrenal Adenoma. AJR Am J Roentgenol 206:1141-1148. https://doi.org/https://doi.org/10.2214/AJR.15.15318
Mohammed MF, ElBanna KY, Ferguson D, Harris A, Khosa F (2018) Pheochromocytomas Versus Adenoma: Role of Venous Phase CT Enhancement. AJR Am J Roentgenol 210:1073-1078. https://doi.org/https://doi.org/10.2214/AJR.17.18472
Szolar DH, Korobkin M, Reittner P, Berghold A, Bauernhofer T, Trummer H, Schoellnast H, Preidler KW, Samonigg H (2005) Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT. Radiology 234:479-485. https://doi.org/https://doi.org/10.1148/radiol.2342031876
Blake MA, Kalra MK, Maher MM, Sahani DV, Sweeney AT, Mueller PR, Hahn PF, Boland GW (2004) Pheochromocytoma: an imaging chameleon. Radiographics 24 Suppl 1:S87-99. https://doi.org/https://doi.org/10.1148/rg.24si045506
Park BK, Kim CK, Kim B, Kwon GY (2007) Adrenal tumors with late enhancement on CT and MRI. Abdom Imaging 32:515-518. https://doi.org/https://doi.org/10.1007/s00261-006-9156-2
Zhang YM, Lei PF, Chen MN, Lv XF, Ling YH, Cai PQ, Gao JM (2016) CT findings of adrenal schwannoma. Clin Radiol 71:464-470. https://doi.org/https://doi.org/10.1016/j.crad.2016.01.010
Kodama Y, Ng CS, Wu TT, Ayers GD, Curley SA, Abdalla EK, Vauthey JN, Charnsangavej C (2007) Comparison of CT methods for determining the fat content of the liver. American Journal of Roentgenology 188:1307-1312
Motta-Ramirez GA, Remer EM, Herts BR, Gill IS, Hamrahian AH (2005) Comparison of CT findings in symptomatic and incidentally discovered pheochromocytomas. AMERICAN JOURNAL OF ROENTGENOLOGY-NEW SERIES- 185:684
Terzolo M, Stigliano A, Chiodini I, Loli P, Furlani L, Arnaldi G, Reimondo G, Pia A, Toscano V, Zini M (2011) AME position statement on adrenal incidentaloma. European journal of endocrinology 164:851-870
Acknowledgements
We would like to express our sincere gratitude to Dr. Sung Yoon Park for his valuable insights and guidance throughout this research.
Funding
No funds, grants, or other support was received.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors have no relevant financial or non-financial interests to disclose.
Ethical approval
Ethical approval was waived by the local Ethics Committee of Samsung Medical center and Kangbuk Samsung Hospital in view of the retrospective nature of the study and all the procedures being performed were part of the routine care.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Kwak, M.H., Yun, JS., Kim, J.N. et al. Validation of the modified CT criteria for identifying non-adenomas. Abdom Radiol (2024). https://doi.org/10.1007/s00261-024-04206-x
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00261-024-04206-x